Back
TransCode Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
6
RNAZ
TransCode Therapeutics, Inc.
Last Price:
$7.31
Seasonality Move:
-51.12%
7 Day Trial
ALL ACCESS PASS
$
7
TransCode Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, TransCode Therapeutics, Inc. has on average historically fallen by 87.9% based on the past 4 years of stock performance.
-
TransCode Therapeutics, Inc. has fallen lower in 4 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
-
Is TransCode Therapeutics, Inc. Stock Undervalued?The current TransCode Therapeutics, Inc. [RNAZ] share price is $7.43. The Score for RNAZ is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
-
RNAZ is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
Will TransCode Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, TransCode Therapeutics, Inc. has on average historically fallen by 87.9% based on the past 4 years of stock performance.
TransCode Therapeutics, Inc. Stock Rating
Sell
6
TransCode Therapeutics, Inc. (RNAZ)
is a Sell
Is TransCode Therapeutics, Inc. overpriced?
-
TransCode Therapeutics, Inc. has fallen lower in 4 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
TransCode Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
transcodetherapeutics.com
52-Week Data
52-Week High:
468.44
52-Week Low:
6.15
Prediction Charts
Market Cap:
6.2M
Price in USD:
7.43
Volume:
5.6K
Beta:
1.53
Technical Analysis
SMA50:
10.16
SMA100:
10.59
SMA200:
10.90
52-Wk Change:
-92.46%
Stock Predictions
-
Is TransCode Therapeutics, Inc. stock public?Yes, TransCode Therapeutics, Inc. is a publicly traded company.
-
What is the TransCode Therapeutics, Inc. stock quote today?The TransCode Therapeutics, Inc. stock price is 7.43 USD today.
-
How to buy TransCode Therapeutics, Inc. stock online?You can buy TransCode Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-4 | 8.48 | 8.64 | 8.78 | 8.45 |
| Dec-5 | 8.64 | 8.61 | 9.00 | 8.45 |
| Dec-8 | 8.36 | 8.35 | 8.69 | 8.25 |
| Dec-9 | 8.50 | 8.41 | 8.50 | 8.20 |
| Dec-10 | 8.35 | 8.63 | 9.31 | 8.35 |
| Dec-11 | 9.80 | 10.42 | 11.28 | 9.53 |
| Dec-12 | 9.94 | 9.51 | 10.25 | 9.28 |
| Dec-15 | 9.56 | 9.07 | 9.58 | 8.69 |
| Dec-16 | 9.21 | 9.11 | 9.31 | 9.00 |
| Dec-17 | 8.90 | 8.46 | 9.16 | 8.26 |
| Dec-18 | 8.46 | 7.85 | 9.24 | 7.21 |
| Dec-19 | 7.61 | 7.92 | 8.30 | 7.61 |
| Dec-22 | 8.18 | 7.60 | 8.43 | 7.10 |
| Dec-24 | 7.15 | 7.43 | 7.67 | 7.14 |
TransCode Therapeutics, Inc. Earnings
TransCode Therapeutics, Inc. Earnings Report: Per Share TransCode Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
TransCode Therapeutics, Inc. Forecast Revenue Growth
TransCode Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for TransCode Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $131.65 per share, and an increase next year of $1.31 per share.
* TransCode Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.